Aviva’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-69,824
| Closed | -$12.8M | – | 1013 |
|
|
2021
Q2 | $12.8M | Sell |
69,824
-608
| -0.9% | -$104K | 0.06% | 325 |
|
|
2021
Q1 | $10.8M | Sell |
70,432
-10,645
| -13% | -$1.65M | 0.05% | 324 |
|
|
2020
Q4 | $12.7M | Sell |
81,077
-7,431
| -8% | -$955K | 0.07% | 275 |
|
|
2020
Q3 | $10.1M | Sell |
88,508
-2,971
| -3% | -$321K | 0.06% | 277 |
|
|
2020
Q2 | $10.3M | Buy |
91,479
+41,962
| +85% | +$4.45M | 0.06% | 267 |
|
|
2020
Q1 | $4.45M | Sell |
49,517
-2,027
| -4% | -$199K | 0.03% | 429 |
|
|
2019
Q4 | $5.57M | Sell |
51,544
-2,297
| -4% | -$246K | 0.03% | 438 |
|
|
2019
Q3 | $5.27M | Sell |
53,841
-90,321
| -63% | -$10.2M | 0.04% | 406 |
|
|
2019
Q2 | $18.9M | Sell |
144,162
-1,964
| -1% | -$253K | 0.13% | 154 |
|
|
2019
Q1 | $19.8M | Buy |
146,126
+317
| +0.2% | +$39.4K | 0.13% | 160 |
|
|
2018
Q4 | $14.2M | Sell |
145,809
-20,940
| -13% | -$2.48M | 0.11% | 192 |
|
|
2018
Q3 | $23.2M | Sell |
166,749
-6,650
| -4% | -$834K | 0.13% | 170 |
|
|
2018
Q2 | $21.5M | Sell |
173,399
-2,273
| -1% | -$266K | 0.13% | 174 |
|
|
2018
Q1 | $19.6M | Buy |
175,672
+3,671
| +2% | +$439K | 0.12% | 183 |
|
|
2017
Q4 | $20.6M | Sell |
172,001
-16,986
| -9% | -$2.07M | 0.12% | 202 |
|
|
2017
Q3 | $26.5M | Buy |
188,987
+2,122
| +1% | +$288K | 0.14% | 162 |
|
|
2017
Q2 | $22.7M | Buy |
186,865
+22,102
| +13% | +$2.57M | 0.13% | 188 |
|
|
2017
Q1 | $20M | Sell |
164,763
-7,727
| -4% | -$996K | 0.11% | 204 |
|
|
2016
Q4 | $21.1M | Buy |
172,490
+9,434
| +6% | +$1.15M | 0.13% | 187 |
|
|
2016
Q3 | $20M | Sell |
163,056
-893
| -0.5% | -$115K | 0.12% | 196 |
|
|
2016
Q2 | $19.1M | Buy |
163,949
+40,438
| +33% | +$5.74M | 0.13% | 178 |
|
|
2016
Q1 | $17.2M | Buy |
123,511
+1,308
| +1% | +$192K | 0.13% | 172 |
|
|
2015
Q4 | $23.3M | Sell |
122,203
-85
| -0.1% | -$14.8K | 0.18% | 128 |
|
|
2015
Q3 | $19.1M | Buy |
122,288
+8,043
| +7% | +$1.47M | 0.16% | 158 |
|
|
2015
Q2 | $20.7M | Buy |
114,245
+6,340
| +6% | +$1.09M | 0.15% | 164 |
|
|
2015
Q1 | $18.7M | Buy |
107,905
+26,926
| +33% | +$4.87M | 0.13% | 182 |
|
|
2014
Q4 | $15M | Sell |
80,979
-80
| -0.1% | -$14.8K | 0.12% | 202 |
|
|
2014
Q3 | $13.4M | Sell |
81,059
-40
| -0% | -$6.57K | 0.11% | 218 |
|
|
2014
Q2 | $12.7M | Buy |
81,099
+10
| +0% | +$1.58K | 0.1% | 237 |
|
|
2014
Q1 | $12.3M | Buy |
81,089
+4,650
| +6% | +$739K | 0.1% | 224 |
|
|
2013
Q4 | $10.2M | Buy |
76,439
+3,340
| +5% | +$401K | 0.09% | 264 |
|
|
2013
Q3 | $8.49M | Buy |
73,099
+17,545
| +32% | +$1.92M | 0.07% | 286 |
|
|
2013
Q2 | $5.12M | Buy |
+55,554
| New | +$5.35M | 0.05% | 346 |
|
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM